The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125541971 12554197 1 I 20160706 20160713 20160713 PER US-BAYER-2016-132831 BAYER 66.00 YR E M Y 0.00000 20160713 PH US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125541971 12554197 1 PS NEXAVAR SORAFENIB 1 400 MG, BID BXH9XU1 21923 400 MG FILM-COATED TABLET BID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125541971 12554197 1 Hepatic cancer

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
125541971 12554197 Alopecia
125541971 12554197 Diarrhoea
125541971 12554197 Dry skin

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found